Connect Biopharma Holdings (CNTB) Invested Capital (2023 - 2025)
Historic Invested Capital for Connect Biopharma Holdings (CNTB) over the last 3 years, with Q3 2025 value amounting to $55.4 million.
- Connect Biopharma Holdings' Invested Capital changed N/A to $55.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.4 million, marking a year-over-year change of. This contributed to the annual value of $92.2 million for FY2024, which is 919.34% down from last year.
- According to the latest figures from Q3 2025, Connect Biopharma Holdings' Invested Capital is $55.4 million.
- In the past 5 years, Connect Biopharma Holdings' Invested Capital ranged from a high of $128.7 million in Q2 2023 and a low of $55.4 million during Q3 2025
- Moreover, its 3-year median value for Invested Capital was $92.2 million (2024), whereas its average is $91.8 million.
- In the last 5 years, Connect Biopharma Holdings' Invested Capital tumbled by 919.34% in 2024 and then plummeted by 3542.48% in 2025.
- Quarter analysis of 3 years shows Connect Biopharma Holdings' Invested Capital stood at $101.5 million in 2023, then fell by 9.19% to $92.2 million in 2024, then tumbled by 39.92% to $55.4 million in 2025.
- Its Invested Capital stands at $55.4 million for Q3 2025, versus $71.3 million for Q2 2025 and $82.9 million for Q1 2025.